Homocysteine metabolism and effects of folic acid supplementation in patients affected with spina bifida

Neuropediatrics

Volumn 31, Issue 6, 2000, Pages 298-302

  Brouwer, I A ^a   Van Dusseldorp, M ^a   Thomas, C M G ^a   Van der Put, N M J ^a   Gaytant, M A ^a   Eskes, T K A B ^a   Hautvast, J G A J ^a   Steegers Theunissen, R P M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Folate; Folic acid; Homocysteine; Spina bifida

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; METHIONINE; PLACEBO;

ADOLESCENT; ADULT; AMINO ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; MALE; NEURAL TUBE DEFECT; PRIORITY JOURNAL; SPINA BIFIDA; VITAMIN SUPPLEMENTATION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; HEMATINICS; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; SPINAL DYSRAPHISM; TREATMENT OUTCOME;

EID: 0034467948     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-12953     Document Type: Article

References (26)

1. Elevated plasma total homocysteine and C677 T mutation of the methylenetetrahydrofolate reductase gene in patients with spina bifida
2. Low-dose folic acid supplementation decreases plasma homocysteine: A randomized trial
3. Maternal-fetal folate status and neural tube defects: A case control study
4. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects
5. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation
6. Vitamin supplementation reduces blood homocysteine levels - A controlled trial in patients with venous thrombosis and healthy volunteers
7. Folic acid and vitamin B6 supplementation and plasma homocysteine concentrations in healthy young women
8. Folate and vitamin B12 concentrations in maternal and fetal blood, and amniotic fluid in second trimester pregnancies complicated by neural tube defects
9. Homocysteine and other thiols in plasma and urine: Automated determination and sample stability
10. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
11. Amniotic fluid folate, vitamin B12 and transcobalamin in neural tube defects
12. Evaluation of the MTHFR C677 T allele and the MTHFR gene locus in a German spina bifida population
13. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
14. 6) in whole blood by high-performance liquid chromatography (HPLC)
15. Maternal hyperhomocysteinemia: A risk factor for neural-tube defects?
16. Neural tube defects and elevated homocysteine levels in amniotic fluid
17. Three different methods for the determination of total homocysteine in plasma
18. 12 concentrations in pregnancies affected by neural tube defects
19. Food standards: Amendment of the standards of identity for enriched grain products to require addition of folic acid
20. Is the common 677 C-T mutation in the methylenetetrahydrafolate reductase gene a risk factor for neural tube defects? A meta-analysis
21. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida
22. 12 metabolism in families with spina bifida offspring
23. Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid
24. Nutrient levels in amniotic fluid from women with normal and neural tube defect pregnancies
25. A genetic defect in 5,10-methylenetetrahydrofolate reductase in neural tube defects